Table 2 Demographic and clinical characteristic associated with the survival of cervical cancer patients, TASH, Addis Ababa, Ethiopia, 2008–2012

 Positive

1.00

1.00

 Negative

1.13(0.70,1.81)

1.16(0.70,1.91)

 Unknown

0.77(0.53,1.13)

0.76(0.51,1.15)

 Rural

1.2(0.94,1.51)

1.16(0.91,1.48)

 Urban

1.00

1.00

 < 30

1.00

1.00

 30–39

1.52(0.78,2.97)

1.43(0.73,2.82)

 40–49

1.50(0.78,2.86)

1.47(0.75,2.87)

 50–59

1.12(0.57,2.20)

1.17(0.58,2.36)

 60+

1.83(0.93,3.61)

2.01(1.01,4.05)^a

 I-IIA

1.00

1.00

 IIB-IIIA

1.32(0.86,2.03)

1.22(0.79,1.88)

 IIIB-IVA

3.07(2.00,4.71)

2.60(1.67,4.04)^a

 IVB

3.77(1.13,12.55)

2.54(0.74,8.68)

 Post-operative

1.17(0.45,3.07)

1.04(0.40,2.74)

 Recurrence

2.46(1.21,5.00)

2.77(1.35,5.68)^a

 No anemia ≥12

1.00

1.00

 > 10 and <12

1.82(1.38,2.40)

1.65(1.24,2.20)^a

 8–10

2.20(1.54,3.14)

1.84(1.27,2.66)^a

 < 8 and ≥5

1.47(0.90,2.42)

1.35(0.81,2.25)

 < 5

1.24(0.67,2.31)

1.12(0.60,2.10)

 Unknown

1.74(0.23,12.73)

1.21(0.16,8.96)

 No co-morbidity

1.00

1.00

 Any co-morbidity

0.98(0.68,1.40)

0.99(0.68,1.43)